Platform technology to deliver prophylactic molecules orally: An example using the Class A select agent Yersinia pestis

Vaccine

Volumn 28, Issue 41, 2010, Pages 6714-6722

  del Rio, Beatriz ^a,b   Fuente, Jesus Lajara ^a,b   Neves, Vera ^c   Dattwyler, Raymond ^c,d   Seegers, Jos F M L ^e   Gomes Solecki, Maria ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Biopeptides Corp   (United States)

^c Biopeptides Corp   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

^e Lactrys Biopharmaceuticals BV   (Netherlands)

Author keywords

Lactobacillus; LcrV; Oral vaccine; Yersinia pestis

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; LOW CALCIUM RESPONSE V ANTIGEN; OUTER SURFACE PROTEIN A; PEPTIDOGLYCAN; RECOMBINANT VACCINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BORRELIA BURGDORFERI; CELL POLARITY; COLON CARCINOMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG DELIVERY SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOSTIMULATION; LACTOBACILLUS PLANTARUM; LUNG; LUNG LAVAGE; LYME DISEASE; MOLECULAR CLONING; MUCOSAL IMMUNITY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEQUENCE ANALYSIS; STATISTICAL SIGNIFICANCE; TH1 CELL; TH2 CELL; VAGINA; VAGINAL LAVAGE; YERSINIA PESTIS;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; ANTIGENS, BACTERIAL; CELL LINE, TUMOR; CYTOKINES; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNITY, MUCOSAL; LACTOBACILLUS PLANTARUM; MICE; MICE, INBRED BALB C; PLAGUE; PLAGUE VACCINE; PORE FORMING CYTOTOXIC PROTEINS; RECOMBINANT PROTEINS; YERSINIA PESTIS;

EID: 77956458541     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.07.084     Document Type: Article

References (50)

1. Wells J.M., Mercenier A. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol 2008, 6(May (5)):349-362.
2. Anderson R., Dougan G., Roberts M. Delivery of the Pertactin/P.69 polypeptide of Bordetella pertussis using an attenuated Salmonella typhimurium vaccine strain: expression levels and immune response. Vaccine 1996, 14(October (14)):1384-1390.
3. Ascon M.A., Hone D.M., Walters N., Pascual D.W. Oral immunization with a Salmonella typhimurium vaccine vector expressing recombinant enterotoxigenic Escherichia coli K99 fimbriae elicits elevated antibody titers for protective immunity. Infect Immun 1998, 66(November (11)):5470-5476.
4. Kohler J.J., Pathangey L., Hasona A., Progulske-Fox A., Brown T.A. Long-term immunological memory induced by recombinant oral Salmonella vaccine vectors. Infect Immun 2000, 68(July (7)):4370-4373.
5. Peters C., Peng X., Douven D., Pan Z.K., Paterson Y. The induction of HIV Gag-specific CD8+ T cells in the spleen and gut-associated lymphoid tissue by parenteral or mucosal immunization with recombinant Listeria monocytogenes HIV Gag. J Immunol 2003, 170(May (10)):5176-5187.
6. Shata M.T., Reitz M.S., DeVico A.L., Lewis G.K., Hone D.M. Mucosal and systemic HIV-1 Env-specific CD8(+) T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector. Vaccine 2001, 20(November (3-4)):623-629.
7. Wu C.M., Chung T.C. Mice protected by oral immunization with Lactobacillus reuteri secreting fusion protein of Escherichia coli enterotoxin subunit protein. FEMS Immunol Med Microbiol 2007, 50(August (3)):354-365.
8. Kajikawa A., Satoh E., Leer R.J., Yamamoto S., Igimi S. Intragastric immunization with recombinant Lactobacillus casei expressing flagellar antigen confers antibody-independent protective immunity against Salmonella enterica serovar. Enteritidis Vaccine 2007, 25(May (18)):3599-3605.
9. Li Y.G., Tian F.L., Gao F.S., Tang X.S., Xia C. Immune responses generated by Lactobacillus as a carrier in DNA immunization against foot-and-mouth disease virus. Vaccine 2007, 25(January (5)):902-911.
10. Lee J.S., Poo H., Han D.P., Hong S.P., Kim K., Cho M.W., et al. Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice. J Virol 2006, 80(April (8)):4079-4087.
11. Pouwels P.H., Vriesema A., Martinez B., Tielen F.J., Seegers J.F., Leer R.J., et al. Lactobacilli as vehicles for targeting antigens to mucosal tissues by surface exposition of foreign antigens. Methods Enzymol 2001, 336:369-389.
12. Shaw D.M., Gaerthe B., Leer R.J., Van Der Stap J.G., Smittenaar C., Heijne Den Bak-Glashouwer M., et al. Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C-expressing lactobacilli. Immunology 2000, 100(August (4)):510-518.
13. Grangette C., Muller-Alouf H., Geoffroy M., Goudercourt D., Turneer M., Mercenier A. Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence. Vaccine 2002, 20(September (27-28)):3304-3309.
14. del Rio B., Dattwyler R.J., Aroso M., Neves V., Meirelles L., Seegers J.F., et al. Oral immunization with recombinant Lactobacillus plantarum induces a protective immune response in mice with Lyme disease. Clin Vaccine Immunol 2008, 15(September (9)):1429-1435.
15. Del Rio B., Seegers J.F.M.L., Gomes-Solecki M. Immune response to Lactobacillus plantarum expressing Borrelia burgdorferi OspA is modulated by the lipid modification of the antigen. PloS One 2010, 5(June (6)):e11199.
16. Leary S.E., Williamson E.D., Griffin K.F., Russell P., Eley S.M., Titball R.W. Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague. Infect Immun 1995, 63(August (8)):2854-2858.
17. Alpar H.O., Eyles J.E., Williamson E.D., Somavarapu S. Intranasal vaccination against plague, tetanus and diphtheria. Adv Drug Deliv Rev 2001, 51(September (1-3)):173-201.
18. Gomes-Solecki M.J., Savitt A.G., Rowehl R., Glass J.D., Bliska J.B., Dattwyler R.J. LcrV capture enzyme-linked immunosorbent assay for detection of Yersinia pestis from human samples. Clin Diagn Lab Immunol 2005, 12(February (2)):339-346.
19. Kyte J., Doolittle R.F. A simple method for displaying the hydropathic character of a protein. J Mol Biol 1982, 157(May (1)):105-132.
20. Radolf J.D., Chamberlain N.R., Clausell A., Norgard M.V. Identification and localization of integral membrane proteins of virulent Treponema pallidum subsp. pallidum by phase partitioning with the nonionic detergent triton X-114. Infect Immun 1988, 56(February (2)):490-498.
21. Neutra M.R., Kozlowski P.A. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 2006, 6(February (2)):148-158.
22. Livingston M., Loach D., Wilson M., Tannock G.W., Baird M. Gut commensal Lactobacillus reuteri 100-23 stimulates an immunoregulatory response. Immunol Cell Biol 2006, 88(January (1)):99-102.
23. Mileti E., Matteoli G., Iliev I.D., Rescigno M. Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS One 2009, 4(9):e7056.
24. Mohamadzadeh M., Duong T., Hoover T., Klaenhammer T.R. Targeting mucosal dendritic cells with microbial antigens from probiotic lactic acid bacteria. Expert Rev Vaccines 2008, 7(March (2)):163-174.
25. Kanzato H., Fujiwara S., Ise W., Kaminogawa S., Sato R., Hachimura S. Lactobacillus acidophilus strain L-92 induces apoptosis of antigen-stimulated T cells by modulating dendritic cell function. Immunobiology 2008, 213(5):399-408.
26. Chuang L., Wu K.G., Pai C., Hsieh P.S., Tsai J.J., Yen J.H., et al. Heat-killed cells of lactobacilli skew the immune response toward T helper 1 polarization in mouse splenocytes and dendritic cell-treated T cells. J Agric Food Chem 2007, 55(December (26)):11080-11086.
27. O'Mahony L., O'Callaghan L., McCarthy J., Shilling D., Scully P., Sibartie S., et al. Differential cytokine response from dendritic cells to commensal and pathogenic bacteria in different lymphoid compartments in humans. Am J Physiol Gastrointest Liver Physiol 2006, 290(April (4)):G839-G845.
28. Smits H.H., Engering A., van der Kleij D., de Jong E.C., Schipper K., van Capel T.M., et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 2005, 115(June (6)):1260-1267.
29. Mohamadzadeh M., Olson S., Kalina W.V., Ruthel G., Demmin G.L., Warfield K.L., et al. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci U S A 2005, 102(February (8)):2880-2885.
30. Hart A.L., Lammers K., Brigidi P., Vitali B., Rizzello F., Gionchetti P., et al. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 2004, 53(November (11)):1602-1609.
31. Christensen H.R., Frokiaer H., Pestka J.J. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 2002, 168(January (1)):171-178.
32. Erickson K.L., Hubbard N.E. Probiotic immunomodulation in health and disease. J Nutr 2000, 130(February (2S Suppl.)):403S-409S.
33. Macpherson A.J., Harris N.L. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 2004, 4(June (6)):478-485.
34. Perdigon G., Alvarez S., Pesce de Ruiz Holgado A. Immunoadjuvant activity of oral Lactobacillus casei: influence of dose on the secretory immune response and protective capacity in intestinal infections. J Dairy Res 1991, 58(November (4)):485-496.
35. Link-Amster H., Rochat F., Saudan K.Y., Mignot O., Aeschlimann J.M. Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol Med Microbiol 1994, 10(November (1)):55-63.
36. Pouwels P.H., Leer R.J., Boersma W.J. The potential of Lactobacillus as a carrier for oral immunization: development and preliminary characterization of vector systems for targeted delivery of antigens. J Biotechnol 1996, 44(January (1-3)):183-192.
37. Maassen C.B., Laman J.D., den Bak-Glashouwer M.J., Tielen F.J., van Holten-Neelen J.C., Hoogteijling L., et al. Instruments for oral disease-intervention strategies: recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis. Vaccine 1999, 17(April (17)):2117-2128.
38. Kalinski P., Hilkens C.M., Wierenga E.A., Kapsenberg M.L. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol Today 1999, 20(December (12)):561-567.
39. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392(March (6673)):245-252.
40. Kronin V., Hochrein H., Shortman K., Kelso A. Regulation of T cell cytokine production by dendritic cells. Immunol Cell Biol 2000, 78(June (3)):214-223.
41. Rescigno M., Urbano M., Valzasina B., Francolini M., Rotta G., Bonasio R., et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001, 2(April (4)):361-367.
42. Chieppa M., Rescigno M., Huang A.Y., Germain R.N. Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement. J Exp Med 2006, 203(December (13)):2841-2852.
43. Niess J.H., Brand S., Gu X., Landsman L., Jung S., McCormick B.A., et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 2005, 307(January (5707)):254-258.
44. Rimoldi M., Chieppa M., Salucci V., Avogadri F., Sonzogni A., Sampietro G.M., et al. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol 2005, 6(May (5)):507-514.
45. Iliev I.D., Mileti E., Matteoli G., Chieppa M., Rescigno M. Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning. Mucosal Immunol 2009, 2(July (4)):340-350.
46. Iliev I.D., Spadoni I., Mileti E., Matteoli G., Sonzogni A., Sampietro G.M., et al. Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells. Gut 2009, 58(November (11)):1481-1489.
47. Macpherson A.J., Uhr T. Compartmentalization of the mucosal immune responses to commensal intestinal bacteria. Ann N Y Acad Sci 2004, 1029(December):36-43.
48. Mowat A.M. Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 2003, 3(April (4)):331-341.
49. Sansonetti P.J. War and peace at mucosal surfaces. Nat Rev Immunol 2004, 4(December (12)):953-964.
50. Daniel C., Repa A., Wild C., Pollak A., Pot B., Breiteneder H., et al. Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1. Allergy 2006, 61(July (7)):812-819.